Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hayat

Showing results (131-140 of 299) with videos related to

Pageof 30
Sort By:
Bulletin Du Cancer|January 1, 1974
[Leukemic transformation of non-hodgkinian hematosarcomas (lymphomas). Efficacity of immunotherapy]G Mathé, P Pouillart, L Schwarzenberg, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1979
Comparative pharmacology of three new nitrosourea analogues: RFCNU, RPCNU, and chlorozotocin. I. Oncostatic effects in miceM Hayat, C Bourut, E Chenu, et al.
Le Journal Medical Libanais. the Lebanese Medical Journal|January 1, 1975
Cure expectancy in children with acute lymphoid leukemiaG Mathe, J L Amiel, P Pouillart, et al.
Recenti Progressi in Medicina|October 1, 1975
[Recent data on the immunotherapy of leukemias]G Mathe, L Schwarzenberg, J L Amiel, et al.
Folia Clinica Internacional|April 1, 1974
[Cure expectancy in children with acute lymphoid leukemia (author's transl)]G Mathé, J L Amiel, P Pouillart, et al.
National Cancer Institute Monograph|May 1, 1973
Survival after recurrence: prognostic factors and spread patterns in clinical stages I and II of Hodgkin's diseaseM Tubiana, B van der Werf-Messing, A Laugier, et al.
European Journal of Haematology|November 1, 1996
Retinoic acid syndrome (RAS) in an aplasic patient with secondary acute promyelocytic leukemia (APL)L Castagna, T Bendahamane, J H Bourhis, et al.
Proceedings of the Royal Society of Medicine|April 1, 1975
New experimental and clinical data on leukaemia immunotherapyG Mathé, L Schwarzenberg, J L Amiel, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1989
Risk of secondary acute leukemia and preleukemia after Hodgkin's disease: the Institut Gustave-Roussy experienceM Henry-Amar, B Pellae-Cosset, C Bayle-Weisgerber, et al.
La Presse Medicale|October 31, 1970
[Trial of adriamycin in the treatment of acute leukemia]G Mathé, J L Amiel, M Hayat, et al.
Pageof 30

Showing results (131-140 of 299) with videos related to

Sort By:
Pageof 30
Bulletin Du Cancer|January 1, 1974
[Leukemic transformation of non-hodgkinian hematosarcomas (lymphomas). Efficacity of immunotherapy]G Mathé, P Pouillart, L Schwarzenberg, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1979
Comparative pharmacology of three new nitrosourea analogues: RFCNU, RPCNU, and chlorozotocin. I. Oncostatic effects in miceM Hayat, C Bourut, E Chenu, et al.
Le Journal Medical Libanais. the Lebanese Medical Journal|January 1, 1975
Cure expectancy in children with acute lymphoid leukemiaG Mathe, J L Amiel, P Pouillart, et al.
Recenti Progressi in Medicina|October 1, 1975
[Recent data on the immunotherapy of leukemias]G Mathe, L Schwarzenberg, J L Amiel, et al.
Folia Clinica Internacional|April 1, 1974
[Cure expectancy in children with acute lymphoid leukemia (author's transl)]G Mathé, J L Amiel, P Pouillart, et al.
National Cancer Institute Monograph|May 1, 1973
Survival after recurrence: prognostic factors and spread patterns in clinical stages I and II of Hodgkin's diseaseM Tubiana, B van der Werf-Messing, A Laugier, et al.
European Journal of Haematology|November 1, 1996
Retinoic acid syndrome (RAS) in an aplasic patient with secondary acute promyelocytic leukemia (APL)L Castagna, T Bendahamane, J H Bourhis, et al.
Proceedings of the Royal Society of Medicine|April 1, 1975
New experimental and clinical data on leukaemia immunotherapyG Mathé, L Schwarzenberg, J L Amiel, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1989
Risk of secondary acute leukemia and preleukemia after Hodgkin's disease: the Institut Gustave-Roussy experienceM Henry-Amar, B Pellae-Cosset, C Bayle-Weisgerber, et al.
La Presse Medicale|October 31, 1970
[Trial of adriamycin in the treatment of acute leukemia]G Mathé, J L Amiel, M Hayat, et al.
Pageof 30